Ramaco Resources, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ramaco Resources, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $24.02M | Mar 21, 2018 |
| FY2017 | Sep 30, 2017 | $14.40M | Mar 21, 2018 |
| FY2017 | Jun 30, 2017 | $11.07M | Mar 21, 2018 |
| FY2017 | Mar 31, 2017 | $11.54M | Mar 21, 2018 |
| FY2017 | Dec 31, 2016 | $3.75M | Mar 21, 2018 |
| FY2017 | Sep 30, 2016 | $1.47M | Mar 21, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $2.40M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $3.77M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $6.24M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $11.00M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $12.35M | Feb 18, 2021 |
| FY2020 | Sep 30, 2019 | $16.40M | Feb 18, 2021 |
| FY2020 | Jun 30, 2019 | $22.54M | Feb 18, 2021 |
| FY2020 | Mar 31, 2019 | $16.45M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $9.23M | Feb 20, 2020 |
| FY2019 | Sep 30, 2018 | $12.76M | Feb 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($51.45M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $11.19M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $82.31M | Feb 26, 2026 |
| FY2025 | Jun 20, 2023 | $31.38M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $116.04M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $39.76M | Mar 14, 2024 |
| FY2020 | Dec 31, 2020 | ($4.75M) | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | ($4.78M) | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $2.65M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $1.96M | Feb 18, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($55.96M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $16.64M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $95.25M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $150.39M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $39.53M | Mar 14, 2024 |
| FY2020 | Dec 31, 2020 | ($8.35M) | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | ($7.58M) | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | ($4.30M) | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $1.14M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $1.94M | Feb 18, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.36M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $49.29M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $48.83M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $40.03M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $21.63M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $21.02M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $18.18M | Jan 10, 2023 |
| FY2020 | Dec 31, 2018 | $14.01M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $12.59M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $7.45M | Mar 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.97M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $112.67M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $161.04M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $187.87M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $53.34M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $13.31M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $42.38M | Jan 10, 2023 |
| FY2020 | Dec 31, 2018 | $36.18M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | ($8.47M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($3.86M) | Mar 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 29, 2024 | $3.00M | Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | $82.90M | Mar 14, 2024 |
| FY2023 | Dec 31, 2022 | $123.01M | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | $29.47M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $24.75M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $45.72M | Jan 10, 2023 |
| FY2020 | Dec 31, 2018 | $48.14M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $75.04M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $16.72M | Mar 19, 2019 |
| FY2017 | Dec 31, 2015 | $4.85M | Mar 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.14B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $674.69M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $665.84M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $596.34M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $329.03M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $228.62M | Jan 10, 2023 |
| FY2020 | Dec 31, 2019 | $226.81M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $188.24M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $148.10M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $119.21M | Mar 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $657.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $311.88M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $296.23M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $287.14M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $117.96M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $59.53M | Jan 10, 2023 |
| FY2020 | Dec 31, 2019 | $56.73M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $47.14M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $34.70M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $35.42M | Mar 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $483.57M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $362.81M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $369.61M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $309.20M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $211.07M | Mar 17, 2025 |
| FY2023 | Dec 31, 2020 | $169.10M | Mar 14, 2024 |
| FY2022 | Dec 31, 2019 | $170.08M | Mar 14, 2023 |
| FY2021 | Dec 31, 2018 | $141.11M | Jan 10, 2023 |
| FY2020 | Dec 31, 2017 | $113.40M | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | ($4.99M) | Feb 20, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($311.0K) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $69.53M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $91.94M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $140.05M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $47.07M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $9.81M | Jan 10, 2023 |
| FY2020 | Dec 31, 2019 | $14.72M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | ($10.22M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($35.29M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | ($18.25M) | Mar 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $440.35M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $33.01M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $41.96M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $35.61M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $21.89M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $5.30M | Jan 10, 2023 |
| FY2020 | Dec 31, 2019 | $5.53M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $6.95M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $5.93M | Mar 19, 2019 |
| FY2018 | Dec 31, 2016 | $5.20M | Mar 19, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $467.56M | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | $92.42M | Mar 17, 2025 |
| FY2023 | Dec 31, 2023 | $91.38M | Mar 14, 2024 |
| FY2022 | Dec 31, 2022 | $128.90M | Mar 14, 2023 |
| FY2021 | Dec 31, 2021 | $45.51M | Jan 10, 2023 |
| FY2018 | Dec 31, 2018 | $9.47M | Mar 19, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 26, 2026 |
| FY2025 | Jun 20, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 17, 2025 |
| FY2023 | Jun 20, 2022 | 2 | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2023 | Jun 20, 2021 | 0 | Mar 14, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 18, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 26, 2026 |
| FY2025 | Jun 20, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 17, 2025 |
| FY2023 | Jun 20, 2022 | 2 | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2023 | Jun 20, 2021 | 0 | Mar 14, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 18, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | 44.16M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 44.09M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | 42.71M | Jan 10, 2023 |
| FY2020 | Dec 31, 2019 | 40.95M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 40.08M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 39.56M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 21, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $24.60M | Mar 17, 2025 |
| FY2024 | Dec 31, 2023 | $25.80M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $5.50M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $20.00M | Mar 14, 2023 |